This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Columbia Laboratories Inc (CBRX)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 6.70M 9.92M 20.53M -21.83M
Operating Gains/Losses 19.90K 7.55K -2.53M 5.16M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.05M 1.27M -562.00K 62.53K
(Increase) Decrease in Inventories 46.47K 38.70K -1.40M -94.80K
(Increase) Decrease In Other Current Assets 0.00 425.40K 0.00 0.00
(Decrease) Increase In Payables 314.76K -2.02M -1.87M 1.73M
(Decrease) Increase In Other Current Liabilities -830.47K -217.57K -1.84M -1.87M
(Increase) Decrease In Other Working Capital -199.39K -12.89K 144.86K 124.00K
Other Non-Cash Items -345.10K -5.09M -13.71M 1.64M
Net Cash From Continuing Operations 7.07M 4.34M -1.34M -9.72M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 7.07M 4.34M -1.34M -9.72M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 15.35M 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -522.35K -985.93K -1.31M -42.39K
Acquisitions -14.52M 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 -234.77K 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 3.10M 35.24M
Cash Provided by Financing Activities
Net Cash From Investing Activities 315.10K -1.22M -13.31M 35.20M
Issuance of Debt 0.00 0.00 0.00 15.00M
Cash Used for Financing Activities
Issuance of Capital Stock 10.72K 0.00 3.30M 11.72M
Repayment of Long-Term Debt -72.28K 0.00 0.00 -42.16M
Repurchase of Capital Stock 0.00 -50.00K -125.38K -3.12M
Payment of Cash Dividends -27.50K -29.33K -30.00K -30.00K
Other Financing Charges, Net 0.00 0.00 0.00 0.00
Net Cash From Financing Activities -89.06K -79.33K 3.14M -18.59M
Effect of Exchange Rate Changes 212.72K 46.07K -7.73K -15.48K
Net Change in Cash & Cash Equivalents 7.51M 3.09M -11.52M 6.87M
CBRX News

CBRX Columbia Laboratories Inc

Analysts Ratings for CBRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CBRX ANALYST REPORT

Brokerage Partners

CBRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs